People: Neurocrine Biosciences Inc (NBIX.O)

NBIX.O on Nasdaq

16.07USD
29 Sep 2014
Price Change (% chg)

$0.23 (+1.45%)
Prev Close
$15.84
Open
$15.66
Day's High
$16.29
Day's Low
$15.59
Volume
586,643
Avg. Vol
522,593
52-wk High
$20.29
52-wk Low
$8.57

Search Stocks

Mollica, Joseph 

Brief Biography

Dr. Joseph A. Mollica, Ph.D., is an Independent Director of Neurocrine Biosciences Inc. He has served as a Director of the Company since June 1997 and as Chairman of the Board from 1998 until 2011. From 2004 to 2008, Dr. Mollica served as the Chairman of the Board of Pharmacopeia Drug Discovery, Inc., a biopharmaceutical company focused on drug discovery and development. From 1994 to 2004, Dr. Mollica served as the Chairman of the Board of Directors, President and Chief Executive Officer of Accelrys, Inc., the former parent of Pharmacopeia Drug Discovery. From 1987 to December 1993, Dr. Mollica served as Vice President, Medical Products of DuPont Company and then as President and CEO of DuPont Merck Pharmaceutical Company from 1991 to 1993. At Ciba-Geigy Ltd., where he was employed from 1966 to 1986, he served in a variety of positions of increasing responsibility, rising to Senior Vice President of Ciba-Geigy’s Pharmaceutical Division. Dr. Mollica is currently the Chairman of the Board of Celator Pharmaceuticals, Inc., an oncology focused biotechnology company, and was previously a Director of Cytogen Corporation, Redpoint Bio Corporation and Genencor International. He received his B.S. from the University of Rhode Island, his M.S. and Ph.D. from the University of Wisconsin and his Sc.D.h.c. from the University of Rhode Island.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

William Rastetter

--

Kevin Gorman

2,283,660

Timothy Coughlin

1,200,680

Haig Bozigian

1,068,090

Dimitri Grigoriadis

1,028,550

Christopher O'Brien

1,249,710
As Of 30 Dec 2013
Search Stocks